The Current Status of Platelet Suppressive Drugs in the Treatment of Thrombosis

J Hirsh; M Gent; E Genton

doi:10.1055/s-0038-1647902

Thrombosis and Haemostasis, Table of Contents

Thromb Haemost 1975; 33(03): 406-416
DOI: 10.1055/s-0038-1647902

National Conference on Thrombosis and Hemostasis, Dallas, Texas, 20.—22. November 1974

Schattauer GmbH

The Current Status of Platelet Suppressive Drugs in the Treatment of Thrombosis^[*]

J Hirsh^**

¹Departments of Pathology and Clinical Epidemiology and Biostatistics, McMaster University Medical Centre, Hamilton, Ontario, Canada

²Department of Medicine, University of Colorado Medical Center, Denver, Colorado, U.S.A.

,

M Gent

¹Departments of Pathology and Clinical Epidemiology and Biostatistics, McMaster University Medical Centre, Hamilton, Ontario, Canada

²Department of Medicine, University of Colorado Medical Center, Denver, Colorado, U.S.A.

,

E Genton

¹Departments of Pathology and Clinical Epidemiology and Biostatistics, McMaster University Medical Centre, Hamilton, Ontario, Canada

²Department of Medicine, University of Colorado Medical Center, Denver, Colorado, U.S.A.

› Author Affiliations

Abstract

Full Text

References

References
1 Acheson J, Danta G, Hutchinson E. C. Controlled trial of dipyridamole in cerebral vascular disease. British Medical Journal 1969; 1: 614
2 Acheson J, Hutchinson E. C. Controlled trial of Clofibrate in cerebral vascular disease. Atherosclerosis 1972; 15: 177
3 Blakely J. A, Gent M, Sheth N, Vavrik M, Tannerya R. G. B, Smythe H. A. Platelets, drugs and longevity in a geriatric population. In: Hirsh J, Cade J. F, Gallus A. S, Schonbaum E. (eds.) Platelets Drugs and Thrombosis Karger, Basel; Switzerland: 284 1974
4 Boston Collaborative Study Surveillance Group. Regular aspirin intake and acute myocardial infarction. British Medical Journal 1972; 1: 440
5 Browse N. L, Hall J. H. Effect of dipyridamole on the incidence of clinically detectable deep-vein thrombosis. Lancet 1969; 2: 718
6 Carter A. E, Eban R, Perrett R. D. Prevention of post-operative deep venous thrombosis and pulmonary embolism. British Medical Journal 1971; 1: 312
7 Carter A. E, Eban R. Prevention of post-operative deep venous thrombosis in legs by orally administered hydroxychloroquine sulphate. British Medical Journal 1974; 3: 94
8 Clagett G. P, Schneider P, Rosoff C. B, Salzman E. W. The influence of aspirin on postoperative platelet kinetics and venous thrombosis. (In preparation.) 1974
9 Dyken M. L, Kolar O. J, Jones F. H. Differences in the occurrence of carotid transient ischemic attacks associated with antiplatelet aggregation therapy. Stroke 1973; 4: 732
10 Elwood P. C, Cochrane A. L, Burr M. L, Sweetname P. M, Williams G, Welsby E, Hughes S. J, Renton R. A randomized controlled trial of acetylsalicylic acid in the secondary prevention of mortality from myocardial infarction. British Medical Journal 1974; 1: 436
11 Evans G. Effect of drugs that suppress platelet surface interaction on incidence of amaurosis fugax and transient cerebral ischemia. Surgical Forum 1972; 23: 239
12 Evans G, Gent M. The effect of platelet suppressive drugs on arterial and venous thromboembolism. In: Hirsh J, Cade J. F, Gallus A. S, Schonbaum E. (eds) Platelets. Drugs and Thrombosis Karger, Basel; Switzerland: 1974: 258
13 Feinstein A. R. Clinical Biostatistics: XVIII. The Clofibrate trials: Another dispute about contratrophic therapy. Clinical Pharmacology and Therapeutics 1972; 13: 953
14 Freed M. D, Rosenthal A, Fyler D. Attempts to reduce arterial thrombosis after cardiac catheterization in children: Use of percutaneous technique and aspirin. American Heart Journal 283 87 No. 3 1974;
15 Friedewald W. T, Halperin M. Clofibrate in ischemic heart disease. Annals of Internal Medicine 1972; 76: 821
16 Gent A. E, Brook C. G. D, Foley T. H, Miller T. N. Dipyridamole: A controlled trial of its effect in acute myocardial infarction. British Medical Journal 1968; 4: 366
17 Group of Physicians of the Newcastle Upon Tyne Region. Trial of Clofibrate in the treatment of ischemic heart disease. British Medical Journal 1971; 4: 767
18 Harker L. A, Slichter J. Studies of platelet and fibrinogen kinetics in patients with prosthetic heart valves. New England Journal of Medicine 1970; 283: 1302
19 Harris W. H, Salzman E. W, Athanasoulis C, Waltman A. C, Baum S, De-Sanctis R. W. Comparison of warfarin, low molecular weight dextran, aspirin and subcutaneous heparin in prevention of venous thromboembolism following total hip replacement. (In preparation.) 1974
20 Harrison M. J. G, Marshall J, Meadows J. C, Russell R. W. R. Effect of aspirin in amaurosis fugax. Lancet 1971; 2: 743
21 Heady J. A. A cooperative trial on the primary prevention of ischaemic heart disease using Clofibrate: Design, methods and progress. British World Health Organization 1973; 48: 243
22 Heikinheimo R, Jarvinen K. Acetylsalicylic acid and arteriosclerotic thromboembolic diseases in the aged. Journal of the American Geriatrics Society 1971; 19: 403
23 Hirsh J. Unpublished observations 1974
24 Hynes K. M, Gau G. T, Rutherford B. D, Kazmier F. J, Frye R. L. Effect of aspirin on brachial artery occlusion following brachial arteriotomy for coronary arteriography. Circulation 1973; 47: 554
25 Kaegi A, Pineo G. F, Shimizu A, Trivedi H, Hirsh J, Gent M. Arteriovenous-shunt thrombosis: Prevention by sulfinpyrazone. New England Journal of Medicine 1974; 290: 304
26 Krasno L. R, Kidera G. J. Clofibrate in coronary heart disease. Effect on morbidity and mortality. Journal of the American Medical Association 1972; 219: 845
27 Lindsay R. M, Prentice C. R. M, Ferguson D, Burton J. A, McNicol G. P. Reduction of thrombus formation on dialyser membranes by aspirin and RA 233. Lancet 1972; 2: 1287
28 Medical Research Council (Report of the Steering Committee) Effect of aspirin on postoperative venous thrombosis. Lancet 1972; 2: 441
29 Mundall J, von Kaulla K. N, Austin J. H. Effect of aspirin in amaurosis fugax. Lancet 1972; 1: 92
30 O’Brien J. R. A trial of aspirin in the prevention of post-operative venous thrombosis. Thrombosis et Diathesis Haemorrhagica Suppl. 54: Thrombosis; Mechanisms and Control 1973; 345
31 Paterson J. C. The pathology of venous thrombi. In: Sherry S, Brinkhous K. M, Genton E, Stengle J. M. (eds) Thrombosis. . Proceedings of National Academy of Sciences; Washington D. C: 1969: 321
32 Preston F. E, Emmanuel I. G, Winfield D. A, Malia R. G. Essential thrombocythemia and peripheral gangrene. British Medical Journal 1974; 3: 548
33 Salzman E. W, Harris W. H, De-Sanctis R. W. Reduction in venous thromboembolism by agents affecting platelet function. New England Journal of Medicine 1971; 284 No. 23 1287
34 Scottish Society of Physicians (Research Committee) Ischaemic heart disease: A secondary prevention trial using Clofibrate. British Medical Journal 1971; 4: 775
35 Sevitt S. Venous thrombosis in injured patients (with some observations on pathogenesis). In : Sherry S, Brinkhous K. M, Genton E, Stengle J. M. (eds) Thrombosis. Proceedings of National Academy of Sciences; Washington, D. C.: 1969: 29
36 Steele P, Genton E. Personal communication 1974
37 Sullivan J. M, Harken D. E, Gorlin R. Pharmacologic control of thromboembolic complications of cardiac-valve replacement. New England Journal of Medicine 1971; 284: 1391
38 Vreeken J, van Aken W. G. Spontaneous aggregation of blood platelets as a cause of idiopathic thrombosis and recurrent painful toes and fingers. Lancet 1971; 2: 1394
39 Weily H. S, Steele P. P, Davies H, Pappas G, Genton E. Platelet survival in patients with substitute heart valves. New England Journal of Medicine 1974; 290: 534
40 Zekert F, Kohn F, Vormittag E. Prophylaxis of thromboembolic disease in traumatological patients. Proceedings of IV Congress of International Society on Hemostasis and Thrombosis Vienna 1973: 246

The Current Status of Platelet Suppressive Drugs in the Treatment of Thrombosis[*]

The Current Status of Platelet Suppressive Drugs in the Treatment of Thrombosis^[*]